Brinter® 3D bioprinting application specialists actively contribute to cancer research, keeping up with the future demands of 3D bioprinting. Please take a look at the recent research paper published by our collaborator Misvik Biology:

Mäkelä, R., Arjonen, A., Härmä, V. et al. Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma. BMC Cancer 20, 590 (2020).